4 Smallcap Upper Quarter of 52-Week Range Stocks to Watch for Future Multibagger Potential: Garware Hi-Tech Films, Vijaya Diagnostic, South Indian Bank and Saregama

Upper quarter of 52-week range stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Garware Hi-Tech Films, Vijaya Diagnostic, South Indian Bank and Saregama meet that test, with market caps from Rs 9,972 crore to Rs 16,946 crore and Garware Hi-Tech Films offering the fastest profit growth, 19.26% a year since FY22. Each of these companies has a market capitalisation below Rs 30,000 crore and a share price in the upper quarter of its 52-week range, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation below Rs 30,000 crore and a share price in the upper quarter of its 52-week range, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap below Rs 30,000 crore. Investors screening upper quarter of 52-week range stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Upper Quarter of 52-Week Range Stocks and Why Do They Attract Multibagger Interest?

Upper quarter of 52-week range stocks are shares that trade in the top quarter of the distance between their yearly low and yearly high, a zone that markets usually reserve for businesses with strong momentum. The four here cover polyester films, pathology diagnostics, private banking and music and media.

A price near the top of its yearly range shows that buyers are in control, and profit growth in both the year and the latest quarter gives the move a solid base. Within upper quarter of 52-week range stocks, the four companies show rising profit. For upper quarter of 52-week range stocks, both FY26 and the latest quarter showed growth. Whichever way you read upper quarter of 52-week range stocks, the common thread is rising profit backed by complete financial data. Investors researching upper quarter of 52-week range stocks get a fuller picture by reading growth and valuation together. The table below lines up upper quarter of 52-week range stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use upper quarter of 52-week range stocks as a starting point for your own research.

Upper Quarter of 52-Week Range Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book

Prices are closing prices as of 28 October 2026. South Indian Bank has the lowest PE of the group at 8.45, while Vijaya Diagnostic posts the highest return on equity at 18.07%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Price to Book	52-Week Range (Rs)
Garware Hi-Tech Films	7,140	16,946	43.69	23.09	12.73%	6.38	2,690.70 to 7,990.00
Vijaya Diagnostic Centre	1,442.80	15,004	80.04	60.75	18.07%	15.67	848.00 to 1,593.60
South Indian Bank	54.64	13,394	8.45	12.02	12.51%	1.11	31.50 to 54.97
Saregama India	523.95	9,972	45.09	26.08	12.23%	6.31	307.05 to 574.50

Garware Hi-Tech Films: Debt-to-Equity of 0.01

Garware Hi-Tech Films makes polyester films, including solar control films and paint protection films, for global markets. It reported FY26 revenue of Rs 2,184.95 crore, up 0.98% year on year, and net profit of Rs 338.23 crore, up 2.12%. Net profit has compounded at 19.26% a year since FY22, while revenue has grown 12.96% a year. Operating margin was 23.56% in FY26. The debt-to-equity ratio is 0.01, which keeps interest costs low.

In the June 2026 quarter, revenue rose 28.41% to Rs 652.80 crore and net profit grew 59.78% to Rs 132.65 crore. The share price is up 114.48% over the past year. Domestic institutions raised their holding from 4.89% in June 2025 to 6.35% in June 2026. The stock trades at a PE of 43.69 against an industry PE of 23.09, with a return on equity of 12.73%.

Vijaya Diagnostic: Quarterly Profit Up 37.60%

Vijaya Diagnostic Centre runs diagnostic centres offering pathology and radiology services, with a strong base in South India. It reported FY26 revenue of Rs 835 crore, up 19.34% year on year, and net profit of Rs 172.98 crore, up 20.30%. Net profit has compounded at 11.81% a year since FY22, while revenue has grown 15.13% a year. Operating margin was 43.94% in FY26. The debt-to-equity ratio is 0.44.

The stock trades at a PE of 80.04 against an industry PE of 60.75, with a return on equity of 18.07%. In the June 2026 quarter, revenue rose 22.76% to Rs 239.51 crore and net profit grew 37.60% to Rs 53.10 crore. The share price has gained 141.31% over five years and 38.44% over the past year. Domestic institutions raised their holding from 25.34% in September 2025 to 32.50% in September 2026.

South Indian Bank: Quarterly Profit Up 21.26%

South Indian Bank is a Kerala-based private sector bank with a strong presence in southern India and a growing retail and small business book. It reported FY26 total income of Rs 11,855.28 crore, up 5.60% year on year, and net profit of Rs 1,455.64 crore, up 11.71%. Total income has compounded at 11.68% a year since FY22.

In the September 2026 quarter, total income rose 11.68% to Rs 3,263.80 crore and net profit grew 21.26% to Rs 426.34 crore. The share price has gained 435.97% over five years and 56.15% over the past year. Domestic institutions raised their holding from 11.92% in September 2025 to 16.78% in September 2026. The stock trades at a PE of 8.45 against an industry PE of 12.02, below the sector average, with a return on equity of 12.51%.

Saregama: Debt-to-Equity of 0.04

Saregama India owns one of the largest Indian music catalogues and earns from music licensing, film and series production and consumer products such as Carvaan. It reported FY26 revenue of Rs 1,026.88 crore and net profit of Rs 206.22 crore, up 0.97%. Net profit has compounded at 5.83% a year since FY22, while revenue has grown 13.86% a year. Operating margin was 37.69% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.

The stock trades at a PE of 45.09 against an industry PE of 26.08, with a return on equity of 12.23%. In the June 2026 quarter, revenue rose 21.18% to Rs 267.81 crore and net profit grew 42.10% to Rs 51.88 crore. Domestic institutions raised their holding from 5.22% in June 2025 to 8.60% in June 2026.

Upper Quarter of 52-Week Range Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these upper quarter of 52-week range stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Net Profit Growth (YoY)
Garware Hi-Tech Films	2,184.95	338.23	12.96%	28.41%	2.12%
Vijaya Diagnostic	835	172.98	15.13%	22.76%	20.30%
South Indian Bank	11,855.28	1,455.64	11.68%	11.68%	11.71%
Saregama	1,026.88	206.22	13.86%	21.18%	0.97%

Check the Univest Screener for live data on these upper quarter of 52-week range stocks

Institutional Holding in Garware Hi-Tech Films, Vijaya Diagnostic, South Indian Bank and Saregama

Institutional holding shows who is backing these upper quarter of 52-week range stocks alongside the promoter. The table uses the latest reported quarter for each. Vijaya Diagnostic has the deepest institutional backing, with FII and DII together holding 43.16% as of September 2026. Domestic institutions increased their holding over the past year in Garware Hi-Tech Films (from 4.89% to 6.35%), Vijaya Diagnostic (from 25.34% to 32.50%), South Indian Bank (from 11.92% to 16.78%) and Saregama (from 5.22% to 8.60%).

Stock	Promoter	FII	DII	Public	Quarter
Garware Hi-Tech Films	60.72%	4.22%	6.35%	28.71%	June 2026
Vijaya Diagnostic	52.46%	10.66%	32.50%	4.38%	September 2026
South Indian Bank	Nil	25.57%	16.78%	57.65%	September 2026
Saregama	60.84%	11.50%	8.60%	19.06%	June 2026

Risks to Weigh in Upper Quarter of 52-Week Range Stocks

Being careful with upper quarter of 52-week range stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Garware Hi-Tech Films trades at a PE of 43.69 against an industry PE of 23.09, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Upper Quarter of 52-Week Range Stocks

Picking from upper quarter of 52-week range stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (12.02 to 60.75) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Garware Hi-Tech Films, Vijaya Diagnostic, South Indian Bank and Saregama live prices.

Conclusion

Among upper quarter of 52-week range stocks, Garware Hi-Tech Films stands out for the fastest profit growth, 19.26% a year since FY22, Vijaya Diagnostic for the highest return on equity at 18.07%, South Indian Bank for the biggest five-year price gain at 435.97% and Saregama for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.04. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing upper quarter of 52-week range stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Upper Quarter of 52-Week Range Stocks to Watch

Which are the best upper quarter of 52-week range stocks to watch for multibagger potential?

Ans. Garware Hi-Tech Films, Vijaya Diagnostic, South Indian Bank and Saregama are the 4 names this list highlights, with market caps of Rs 16,946 crore, Rs 15,004 crore, Rs 13,394 crore and Rs 9,972 crore respectively. Garware Hi-Tech Films is notable for the fastest profit growth, 19.26% a year since FY22. Vijaya Diagnostic stands out for the highest return on equity at 18.07%. South Indian Bank offers the biggest five-year price gain at 435.97%. Saregama brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.04. These are watchlist names for upper quarter of 52-week range stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Vijaya Diagnostic a good stock for long-term investors?

Ans. Vijaya Diagnostic has a return on equity of 18.07%, a PE of 80.04 against an industry PE of 60.75 and a market cap of Rs 15,004 crore. Net profit has compounded at 11.81% a year since FY22, and FY26 revenue rose 19.34% while June 2026 quarter net profit grew 37.60%. Long-term returns in upper quarter of 52-week range stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Garware Hi-Tech Films become a multibagger from here?

Ans. Garware Hi-Tech Films has a market cap of Rs 16,946 crore. A multibagger outcome in upper quarter of 52-week range stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 19.26% a year since FY22, and FY26 revenue rose 0.98%. At a PE of 43.69 against an industry PE of 23.09, valuation should be checked against that growth before investing.

What is the market cap of Garware Hi-Tech Films, Vijaya Diagnostic, South Indian Bank and Saregama?

Ans. As of 28 October 2026, Garware Hi-Tech Films has a market cap of Rs 16,946 crore, Vijaya Diagnostic has a market cap of Rs 15,004 crore, South Indian Bank has a market cap of Rs 13,394 crore and Saregama has a market cap of Rs 9,972 crore. All of them qualify as smallcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on upper quarter of 52-week range stocks.

What are the risks of investing in upper quarter of 52-week range stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Garware Hi-Tech Films trades at a PE of 43.69 against an industry PE of 23.09, so earnings growth needs to hold up.

Why is Garware Hi-Tech Films trading at a PE of 43.69?

Ans. Garware Hi-Tech Films’ PE of 43.69 compares with an industry PE of 23.09. The market is paying a premium for profit growth of 19.26% a year since FY22 and latest-quarter profit growth of 59.78%, which also means the stock is more sensitive if growth slows. Investors in upper quarter of 52-week range stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Garware Hi-Tech Films, Vijaya Diagnostic, South Indian Bank and Saregama?

Ans. As of the latest reported quarter, FII and DII together hold 10.57% of Garware Hi-Tech Films (4.22% and 6.35%), 43.16% of Vijaya Diagnostic (10.66% and 32.50%), 42.35% of South Indian Bank (25.57% and 16.78%) and 20.10% of Saregama (11.50% and 8.60%). Rising institutional holding is a useful signal in upper quarter of 52-week range stocks, though it should be read with earnings trends rather than on its own.